​

GE HealthCare (GEHC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GEHC Stock Forecast

GE HealthCare (GEHC) stock forecast, based on 20 Wall Street analysts, predicts a 12-month average price target of $81.14, with a high of $95.00 and a low of $67.00. This represents a -3.12% decline from the last price of $83.75.

$60 $67 $74 $81 $88 $95 High: $95 Avg: $81.14 Low: $67 Last Closed Price: $83.75

GEHC Stock Rating

GE HealthCare stock's rating consensus is Buy, based on 20 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (65.00%), 7 Hold (35.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 20 0 7 13 Strong Sell Sell Hold Buy Strong Buy

GEHC Price Target Upside V Benchmarks

TypeNameUpside
StockGE HealthCare-3.12%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks9.18%

Price Target Trends

1M3M12M
# Anlaysts2328
Avg Price Target$90.00$91.00$84.93
Last Closing Price$83.75$83.75$83.75
Upside/Downside7.46%8.66%1.41%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 266106--22
Oct, 265105--20
Sep, 264105--19
Aug, 264105--19
Jul, 26495--18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 29, 2026Christopher PasqualeBarclays$95.00$75.8225.30%13.43%
Oct 06, 2026Barclays$85.00$64.7731.23%1.49%
Sep 22, 2026Needham$93.00$64.8143.50%11.04%
Jul 30, 2026Evercore ISI$84.00$69.0621.63%0.30%
Jul 29, 2026BTIG$79.00$71.5410.43%-5.67%
Jul 16, 2026UBS$67.00$64.234.31%-20.00%
Jul 13, 2026Ryan ZimmermanBTIG$75.00$64.7015.92%-10.45%
Jul 08, 2026BMO Capital$70.00$64.688.23%-16.42%
Jun 23, 2026RBC Capital$80.00$60.6431.93%-4.48%
May 21, 2026Graham DoyleUBS$69.00$64.267.38%-17.61%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 29, 2026CitigroupNeutralNeutralhold
Oct 29, 2026BarclaysOverweightOverweighthold
Oct 29, 2026Bank of America SecuritiesNeutralNeutralhold
Oct 12, 2026BTIGBuyBuyhold
Oct 06, 2026BarclaysOverweightinitialise
Oct 05, 2026NeedhamBuyBuyhold
Oct 05, 2026RBC CapitalOutperformOutperformhold
Sep 22, 2026NeedhamBuyinitialise
Sep 17, 2026BTIGBuyBuyhold
Jul 30, 2026Evercore ISIOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.22$3.04$4.37$3.68---
Avg Forecast$3.51$3.82$4.30$4.66$5.23$5.75$6.31
High Forecast$3.58$3.83$4.34$4.81$5.43$5.82$6.49
Low Forecast$3.46$3.80$4.28$4.54$4.70$5.68$6.20
Surprise %20.23%-20.42%1.63%-21.03%---

Revenue Forecast

$18B $19B $20B $22B $23B $24B Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$18.34B$19.55B$19.67B$19.60B---
Avg Forecast$18.30B$19.42B$19.68B$20.44B$21.40B$22.33B$23.00B
High Forecast$18.59B$19.52B$19.70B$20.71B$21.43B$22.34B$23.52B
Low Forecast$18.11B$19.35B$19.67B$20.28B$21.37B$22.32B$22.71B
Surprise %0.22%0.66%-0.03%-4.10%---

Net Income Forecast

$2B $2B $2B $2B $3B $3B Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.92B$1.57B$1.99B$1.68B---
Avg Forecast$1.61B$1.75B$1.97B$2.14B$2.31B$2.63B$2.89B
High Forecast$1.64B$1.75B$1.99B$2.20B$2.49B$2.67B$2.97B
Low Forecast$1.59B$1.74B$1.96B$2.08B$2.15B$2.60B$2.84B
Surprise %19.14%-10.16%1.08%-21.58%---

GEHC Forecast FAQ

Is GE HealthCare stock a buy?

GE HealthCare stock has a consensus rating of Buy, based on 20 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that GE HealthCare is a favorable investment for most analysts.

What is GE HealthCare's price target?

GE HealthCare's price target, set by 20 Wall Street analysts, averages $81.14 over the next 12 months. The price target range spans from $67 at the low end to $95 at the high end, suggesting a potential -3.12% change from the previous closing price of $83.75.

How does GE HealthCare stock forecast compare to its benchmarks?

GE HealthCare's stock forecast shows a -3.12% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (9.18%).

What is the breakdown of analyst ratings for GE HealthCare over the past three months?

  • November 2026: 27.27% Strong Buy, 45.45% Buy, 27.27% Hold, 0% Sell, 0% Strong Sell.
  • October 2026: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 21.05% Strong Buy, 52.63% Buy, 26.32% Hold, 0% Sell, 0% Strong Sell.

What is GE HealthCare’s EPS forecast?

GE HealthCare's average annual EPS forecast for its fiscal year ending in December 2026 is $5.23, marking a 42.12% increase from the reported $3.68 in 2025. Estimates for the following years are $5.75 in 2027, and $6.31 in 2028.

What is GE HealthCare’s revenue forecast?

GE HealthCare's average annual revenue forecast for its fiscal year ending in December 2026 is $21.4B, reflecting a 9.19% increase from the reported $19.6B in 2025. The forecast for 2027 is $22.33B, and $23B for 2028.

What is GE HealthCare’s net income forecast?

GE HealthCare's net income forecast for the fiscal year ending in December 2026 stands at $2.31B, representing an 37.76% increase from the reported $1.68B in 2025. Projections indicate $2.63B in 2027, and $2.89B in 2028.